Aus den Augen, aus dem Sinn – Knacknuss-Anamnese bei disseminierten Arzneimittelexanthemen auf „vergessene“ Selbstmedikation

Zusammenfassung

Es werden zwei Patienten vorgestellt, die zur Abklärung unklarer Exantheme zugewiesen wurden, bei beiden wurde die Diagnose initial nicht gestellt. Der erste Patient hatte ein ausgeprägtes Arzneimittelexanthem, die Patientin ein generalisiertes fixes Arzneimittelexanthem. Die wegen Verdacht auf Arzneimittelallergie durchgeführte aufwändige allergologische Diagnostik fiel zunächst unergiebig aus. Bei beiden wurde initial der Auslöser anamnestisch nicht erfasst, da die Patienten die Selbsttherapie mit frei verkäuflichen Medikamenten vergessen hatten oder als nicht relevant betrachteten. Erst auf intensive Befragung konnten die Auslöser Pseudoephedrin bzw. Paracetamol eruiert und bestätigt werden. Die zentrale Rolle einer umfassenden Anamneseerhebung und Dokumentation aller eingenommenen Therapeutika wird dargestellt.

Abstract

Two patients are presented who were referred for evaluation of unclear exanthema, in both of whom the diagnosis was not initially made. The first patient had a disseminated drug exanthema, the female patient a generalized fixed drug exanthema. The extensive allergological diagnostic work-up performed because of a suspected drug allergy was first negative. In both cases, the trigger was initially not obtained in the patient’s history, because both patients had forgotten the self-therapy with over-the-counter medications or considered it irrelevant. Only after intensive questioning could the triggers pseudoephedrine and paracetamol, respectively, be identified and confirmed. The central role of a comprehensive history collection and documentation of all therapeutic agents taken is discussed.

Publication History

Article published online:
14 January 2022

• Literatur

• 1 Levy AG, Scherer AM, Zikmund-Fisher BJ. et al. Prevalence of and Factors Associated With Patient Nondisclosure of Medically Relevant Information to Clinicians. JAMA Netw Open 2018; 1: e185293 DOI: 10.1001/jamanetworkopen.2018.5293.
• 2 Jerez-Roig J, Medeiros LF, Silva VA. et al. Prevalence of self-medication and associated factors in an elderly population: a systematic review. Drugs Aging 2014; 31: 883-896 DOI: 10.1007/s40266-014-0217-x.
• 3 Tanno LK, Fillard A, Landry Q. et al. Ephedrine-induced erythrodermia: Clinical diagnostic procedure and cross-sensitivity. Contact Dermatitis 2018; 79: 43-44 DOI: 10.1111/cod.12980.
• 4 Alanko K, Kanerva L, Mohell-Talolahti B. et al. Nonpigmented fixed drug eruption from pseudoephedrine. J Am Acad Dermatol 1996; 35: 647-648
• 5 Bellini V, Bianchi L, Hansel K. et al. Bullous nonpigmenting multifocal fixed drug eruption due to pseudoephedrine in a combination drug: Clinical and diagnostic observations. J Allergy Clin Immunol Pract 2016; 4: 542-544 DOI: 10.1016/j.jaip.2015.12.005.
• 6 Elices A, Chamorro-Gómez M, Davila G. et al. Nonpigmenting fixed drug eruption due to pseudoephedrine. Allergy: European Journal of Allergy and Clinical Immunology 2010; 65: 697 DOI: 10.1111/j.1398-9995.2010.02395.x.
• 7 Rodriguez M, Porcel S, Alvarado M. et al. Nonpigmenting fixed exanthema induced by pseudoephedrine in a pediatric patient. Allergy: European Journal of Allergy and Clinical Immunology 2010; 65: 254 DOI: 10.1111/j.1398-9995.2010.02393.x.
• 8 Vidal C, Prieto A, Pérez-Carral C. et al. Nonpigmenting fixed drug eruption due to pseudoephedrine. Annals of Allergy, Asthma and Immunology 1998; 80: 309-310 DOI: 10.1016/S1081-1206(10)62974-2.
• 9 Bisconti I, Billahalli T, Gilbert C. et al. Pseudoephedrine induced baboon syndrome confirmed by oral provocation test. Allergy: European Journal of Allergy and Clinical Immunology 2020; 75: 472 DOI: 10.1111/all.14508.
• 10 Moreno-Escobosa MC, De las Heras M, Figueredo E. et al. Generalized dermatitis due to pseudoephedrine. Allergy: European Journal of Allergy and Clinical Immunology 2002; 57: 753 DOI: 10.1034/j.1398-9995.2002.23771.x.
• 11 Tomb RR, Lepoittevin JP, Espinassouze F. et al. Systemic contact dermatitis from pseudoephedrine. Contact Dermatitis 1991; 24: 86-88
• 12 Padial MA, Alvarez-Ferreira J, Tapia B. et al. Acute generalized exanthematous pustulosis associated with pseudoephedrine. Br J Dermatol 2004; 150: 139-142 DOI: 10.1111/j.1365-2133.2004.05717.x.
• 13 Downs A, Lear J, Wallington T. et al. Contact sensitivity and systemic reaction to pseudoephedrine and lignocaine. Contact Dermatitis 1998; 39: 33-34
• 14 Moreno-Escobosa MC, de las Heras M, Figueredo E. et al. Generalized dermatitis due to pseudoephedrine. Allergy 2002; 57: 753
• 15 Taylor B, Duffill M. Recurrent pseudo-scarlatina and allergy to pseudoephedrine hydrochloride. Br J Dermatol 1988; 118: 827-882
• 16 Fontaine JF, Lavaud F, Deslée G. et al. Dermal toxicity to pseudoephidrine: One case. Allerg Immunol (Paris) 2002; 34: 230-232
• 17 Gonzalo-Garijo MA, Pérez-Calderón R, De Argila D. et al. Erythrodermia to pseudoephedrine in a patient with contact allergy to phenylephrine. Allergol Immunopathol (Madr) 2002; 30: 239-242 DOI: 10.1016/S0301-0546(02)79127-1.
• 18 Rochina A, Burches E, Morales C. et al. Adverse reaction to pseudoephedrine. J Investig Allergol Clin Immunol 1995; 5: 235-236
• 19 Venturini M, Lezaun A, Abos T. et al. Immediate hypersensitivity due to pseudoephedrine. Allergy 2002; 57: 52-53
• 20 Barranco R, Rodríguez A, De Barrio M. et al. Sympathomimetic drug allergy: Cross-reactivity study by patch test. Am J Clin Dermatol 2004; 5: 351-355 DOI: 10.2165/00128071-200405050-00008.
• 21 Moser-Oberthaler S, Mueller H, Gattringer C. et al. Delayed type hypersensitivity to phenylephrine. Allergy: European Journal of Allergy and Clinical Immunology 2011; 66: 281 DOI: 10.1111/j.1398-9995.2011.02606.x.
• 22 López Abad R, Iriarte Sotés P, Castro Murga M. et al. Fixed drug eruption induced by phenylephrine: A case of polysensitivity. J Investig Allergol Clin Immunol 2009; 19: 322-323
• 23 Mahboob A, Haroon T. Drugs causing fixed eruptions: a study of 450 cases. Int J Dermatol 1998; 37: 833-838
• 24 Moro Moro M, Acosta Rivera M, Alonso Diaz De Durana M. et al. A case review of fixed drug eruption in an allergy unit. Allergy: European Journal of Allergy and Clinical Immunology 2012; 67: 258-259 DOI: 10.1111/all.12035.
• 25 Kornmehl H, Gorouhi F, Konia T. et al. Generalized fixed drug eruption to piperacillin/tazobactam and review of literature. Dermatol Online J 2018; 24: 14-17
• 26 Patel S, John AM, Handler MZ. et al. Fixed Drug Eruptions: An Update, Emphasizing the Potentially Lethal Generalized Bullous Fixed Drug Eruption. Am J Clin Dermatol 2020; 21: 393-399 DOI: 10.1007/s40257-020-00505-3.
• 27 Fathallah N, Ben Salem C, Slim R. et al. Acetaminophen-induced cellulitis-like fixed drug eruption. Indian J Dermatol 2011; 56: 206-208 DOI: 10.4103/0019-5154.80419.
• 28 Genovese G, Gelmetti C, Spigariolo C. et al. Acetaminophen-induced generalized fixed drug eruption in a 5-year-old girl. Pediatr Dermatol 2020; 37: 756-758 DOI: 10.1111/pde.14161.
• 29 Gil F, Luís P, Parente J. Generalized Bullous Fixed Drug Eruption Induced by Paracetamol. Skinmed 2021; 19: 155-156
• 30 van Zogchel L, Hendriks T, Adriaens S. et al. [A fixed drug eruption caused by paracetamol]. Ned Tijdschr Geneeskd 2016; 160: D470
• 31 Paulmann M, Mockenhaupt M. [Unintended rechallenge : Generalized bullous fixed drug eruption in two elderly women]. Hautarzt 2017; 68: 59-63 DOI: 10.1007/s00105-016-3850-y.
• 32 Braesch C, Weill A, Gaudin O. et al. Relapsing generalized bullous fixed drug eruption: A severe and avoidable cutaneous drug reaction. Three case reports. Therapie 2021; DOI: 10.1016/j.therap.2021.04.004.
• 33 Barootes Hailey C, Peebles Erin R, Matsui D. et al. Severe Generalized Bullous Fixed Drug Eruption Treated with Cyclosporine: A Case Report and Literature Review. Case Rep Dermatol 2021; 13: 154-163 DOI: 10.1159/000513469.